US-China trade war continues, driving ASX down 2pc and oil 4pc. Pharmaceutical tariff threat tanks healthcare sector as resources also fall.

A big mover among small caps was Leeuwin Metals after a review of drilling at Marda gold project pointed to extensive mineralisation.

ASX cops a beating as the US-China trade spat rocks markets, pharma faces tariff pain, oil dives, and Aussie miners take a hit.

Condor has soared on the back of a multi-billion barrel prospective resource in the Tumbes TEA offshore northern Peru.

It’s well-worn but it is worth repeating Warren Buffett’s advice to be greedy when others are fearful and fearful when others are greedy.

ASX takes a beating as US-China trade war escalates, but biotech and rare earth stocks shine despite uncertain market ...

A price turnaround and the prospect of accelerated rate cuts puts residential property back in favour as share markets turn ...

Having won US Food & Drug Administration approval for its nerve repair agent Remplir, Orthocell is wasting no time getting it ...

Firetail Resources (ASX:FTL) moves to refine porphyry potential at Picha project with field programs and geophysics ...

With critical minerals becoming ever more important, Saskatchewan has all the right ingredients to be a major player.

China’s restrictions on exports of medium and heavy rare earths will disrupt global supply chains, opening the door for ...

These sub $10m stocks could be poised to make gains as the gold price smashes the US$3000/oz ceiling and beyond.